Skip to main navigation
Skip to search
Skip to main content
Technical University of Munich Home
Help & FAQ
English
Deutsch
Home
Profiles
Research units
Projects
Research output
Equipment
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
The IPSS-R has prognostic impact in untreated patients with MDS del(5q)
J. Kaivers
, M. Lauseker
, B. Hildebrandt
, P. Fenaux
, M. Pfeilstöcker
, P. Valent
, U. Platzbecker
, R. Latagliata
, E. N. Oliva
, B. Xicoy
,
K. Götze
, C. Ganster
, D. Haase
, G. Bug
, A. Kündgen
, N. Gattermann
, R. Haas
, U. Germing
Department of Internal Medicine III - Hematology and Medical Oncology
Medical Faculty and University Hospital Düsseldorf
University of Munich
Hôpital Saint-Louis
A Karl-Landsteiner Institute
Medical University of Vienna
Technische Universität Dresden
Azienda Policlinico Umbrto I Sapienza University
Grande Ospedale Metropolitano Bianchi Melacrino Morelli
Josep Carreras Leukemia Research Institute
University Medical Center
Klinikum der J. W. Goethe-Universität
Research output
:
Contribution to journal
›
Article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The IPSS-R has prognostic impact in untreated patients with MDS del(5q)'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Prognostic Impact
100%
Untreated Patients
100%
IPSS-R
100%
Ultra-high Risk
40%
Europe
20%
Patient Survival
20%
Low Risk
20%
Aberrations
20%
Clinical High Risk
20%
High-risk Population
20%
Intermediate Risk
20%
Low-risk Patients
20%
Very Low Risk
20%
Prognostic Tool
20%
Deletion 5q
20%
Medicine and Dentistry
Myelodysplastic Syndrome
100%
Refractory Anemia with Excess of Blasts
28%
High Risk Population
14%
Acute Myelogenous Leukemia
14%
Refractory Cytopenia with Multilineage Dysplasia
14%
Pharmacology, Toxicology and Pharmaceutical Science
Myelodysplastic Syndrome
100%
Refractory Anemia with Excess Blasts
28%
Refractory Cytopenia with Multilineage Dysplasia
14%
Immunology and Microbiology
High Risk Population
100%
Biochemistry, Genetics and Molecular Biology
High Risk Population
100%